Arrae, Inc.
About Arrae, Inc.
Company overview
Arrae is a Los Angeles-based wellness company that creates targeted natural supplements designed to address everyday health concerns for women using science-backed, plant-based formulations. Co-founded in 2020 by Siffat Haider and Nish Samantray, Arrae seeks to provide effective, holistic remedies for common ailments such as bloating, anxiety, constipation, and fatigue without the use of harsh chemicals or synthetic additives. Product/Service Line Breakdown: 1. Bloat Capsules Purpose: Designed to alleviate bloating and improve digestion. Key Ingredients: Bromelain, ginger root, dandelion root, slippery elm, lemon balm. Use Case: Post-meal discomfort, indigestion, water retention. Form: Capsules. Science-Backed: Formulated with input from naturopathic doctors (Arrae Bloat). 2. Calm Capsules Purpose: Reduces anxiety, stress, and promotes relaxation. Key Ingredients: L-theanine, magnesium bisglycinate, inositol. Use Case: Daytime stress, social anxiety, travel jitters. Form: Capsules. Benefit: Non-drowsy, non-habit forming (Arrae Calm). 3. Sleep Capsules Purpose: Improves sleep onset and quality. Key Ingredients: Chamomile, melatonin, valerian root, L-theanine. Use Case: Insomnia, jet lag, restlessness. Form: Capsules. Unique Aspect: Supports both sleep quality and next-day alertness (Arrae Sleep). 4. Constipation Capsules Purpose: Relieves occasional constipation and supports gut motility. Key Ingredients: Aloe vera, senna leaf, triphala, fennel seed. Use Case: Irregularity, travel constipation, detox support. Form: Capsules. Note: Gentle, natural, and non-habit forming (Arrae Constipation). 5. Heartburn Capsules Purpose: Neutralizes acidity and relieves acid reflux. Key Ingredients: Marshmallow root, licorice root, slippery elm. Use Case: Post-meal acidity, GERD, reflux prevention. Form: Capsules. Formula: Designed for fast and effective acid relief (Arrae Heartburn).
Keywords
Revenue
EBITDA
Valuation
| Line Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenues | $380 MM | $250 MM | $90 MM | $120 MM | $65 MM |
| Gross Profit | $190 MM | $125 MM | $45 MM | $60 MM | $32.50 MM |
| Net Income (Loss) | $43 MM | $25 MM | $9 MM | $12 MM | $6.50 MM |
| Line Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | $850 MM | $720 MM | $680 MM | $650 MM | $600 MM |
| Total Liabilities | $450 MM | $400 MM | $380 MM | $350 MM | $320 MM |
| Total Equity | $400 MM | $320 MM | $300 MM | $300 MM | $280 MM |
Ratios
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
© 2026 PrivCo Holding Inc. All rights reserved.
No AI Training or Automated Data Extraction.
Use of this page or any content or data made available by PrivCo for scraping, crawling, indexing, caching, extracting, copying, reproducing, storing, or for training or developing any artificial intelligence or machine learning system is strictly prohibited without prior written consent. All access to and use of this page and PrivCo's services are subject to the PrivCo Terms of Use: https://www.privco.com/terms-of-use. No license or right is granted by implication or otherwise.